Prophylactic mechanical circulatory support for protected ventricular tachycardia ablation: A meta-analysis of the literature

S. Mariani*, L.C. Napp, K. Kraaier, T. Li, K. Bounader, J.S. Hanke, G. Dogan, J.D. Schmitto, R. Lorusso

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Acute hemodynamic decompensation (AHD) during ventricular tachycardia (VT) ablation occurs in about 11% of cases. Prophylactic use of temporary mechanical circulatory support (pro-tMCS) has been applied to prevent AHD during VT ablation, but evidence supporting this practice is still lacking. This systematic review and meta-analysis assessed the procedural characteristics and outcomes of pro-tMCS for VT ablation. PubMed/Medline was screened until February 2020. Articles including adults receiving pro-tMCS for VT ablation were included, and a meta-analysis to compare proMCS and no-tMCS was performed. Primary outcome was in-hospital/30-day mortality. Five observational studies presenting 400 procedures (pro-tMCS: n = 187; no-tMCS: n = 213) were included. Baseline characteristics were comparable between groups. Impella and TandemHeart were used in 86.6% and 13.4% of cases, respectively. In the pro-tMCS group, more VTs were induced (mean difference: 0.52, confidence interval [CI]: 0.26-0.77, P < .0001), and patients remained in VT on average for 24.04 minutes longer (CI: 18.28-29.80, P < .00001). Procedural success was comparable between groups, as was VT recurrence. Pro-tMCS patients had an odds ratio of 0.55 (CI: 0.28-1.05, P = .07) for in-hospital/30-day mortality and 0.55 (CI: 0.32-0.94, P = .03) for mortality at follow-up. Sixty-four percent of no-tMCS patients received rescue tMCS. The most common tMCS-related complications were bleeding events. Pro-tMCS allowed for a prolonged time on VTs and the induction of more VTs. Although these advantages were not associated with differences in procedural success, VT recurrence, or in-hospital/30-day mortality in the overall population, pro-tMCS might improve long-term survival. Further prospective studies are urgently needed to confirm these results.

Original languageEnglish
Pages (from-to)987-997
Number of pages11
JournalArtificial Organs
Volume45
Issue number9
DOIs
Publication statusPublished - 1 Sept 2021

Keywords

  • catheter ablation
  • mechanical circulatory support
  • shock
  • ventricular tachycardia
  • CATHETER ABLATION
  • HEMODYNAMIC SUPPORT
  • OUTCOMES
  • PREVENTION
  • MANAGEMENT

Cite this